Profile for Eagle Pharmaceuticals, Inc. (EGRX)
« Back to company indexEGRX Chatter Timeline
Stock Ticker for EGRX
Most Active Tweeters for EGRX
| User | Tweets |
|---|---|
| @TheMarketsDaily | 7 |
| @registrarjourn | 7 |
| @OlympiaReport | 6 |
| @dailypoliticaln | 6 |
| @ZolmaxNews | 6 |
Recent Tweets for EGRX
 |
@IngoDoggy Binance is TEMPORARILY accepting new users! Register link and bonus https://t.co/RdDhUme4JU ? 05/25 04:52 $EGRX… https://t.co/HQDuqIlZeH May 25th 2018, 4:05am |
 |
@sep_sal RT @IncredibleTrade: $EGRX worth watch. https://t.co/6n7xD1Sxq4 May 24th 2018, 10:05pm |
 |
@IncredibleTrade $EGRX worth watch. https://t.co/6n7xD1Sxq4 May 24th 2018, 10:05pm |
 |
@OlympiaReport Eagle Pharmaceuticals $EGRX Receives $68.00 Consensus PT from Brokerages https://t.co/zTeiX7hH4d May 24th 2018, 12:05pm |
 |
@ledgerzette Eagle Pharmaceuticals $EGRX Receives $68.00 Consensus PT from Brokerages https://t.co/jc80OjlaXx May 24th 2018, 12:05pm |
 |
@ZolmaxNews Weekly Investment Analysts’ Ratings Updates for Eagle Pharmaceuticals $EGRX https://t.co/NMMbkvqahk May 23rd 2018, 8:05pm |
|
@ledgerzette Weekly Investment Analysts’ Ratings Updates for Eagle Pharmaceuticals $EGRX https://t.co/Vgdw4PlZwv May 23rd 2018, 8:05pm |
 |
@dailypoliticaln Weekly Investment Analysts’ Ratings Updates for Eagle Pharmaceuticals $EGRX https://t.co/xXJOWcFwdt May 23rd 2018, 8:05pm |
|
@OlympiaReport Eagle Pharmaceuticals $EGRX Expected to Post Quarterly Sales of $51.50 Million https://t.co/sv1GcX1k8d May 23rd 2018, 7:05pm |
 |
@WeekHerald Analysts Anticipate Eagle Pharmaceuticals $EGRX Will Post Earnings of $0.96 Per Share https://t.co/qSK4qTCuz4 May 23rd 2018, 7:05pm |
 |
@registrarjourn Eagle Pharmaceuticals $EGRX Expected to Post Quarterly Sales of $51.50 Million https://t.co/G5mNCsTlX8 May 23rd 2018, 7:05pm |
 |
@ThisLincolnian Eagle Pharmaceuticals $EGRX Rating Increased to Strong-Buy at BidaskClub https://t.co/qPTBALRCCI May 23rd 2018, 6:05am |
 |
@TranscriptDaily Eagle Pharmaceuticals $EGRX Rating Increased to Strong-Buy at BidaskClub https://t.co/by5tpwCuxo May 23rd 2018, 1:05am |
|
@ZolmaxNews Eagle Pharmaceuticals $EGRX Rating Increased to Strong-Buy at BidaskClub https://t.co/dF5J2Z0zUl May 23rd 2018, 1:05am |
 |
@TheMarketsDaily Eagle Pharmaceuticals $EGRX Expected to Post Quarterly Sales of $51.50 Million https://t.co/jzFPiKnGfV May 21st 2018, 10:05am |
|
@WeekHerald Eagle Pharmaceuticals $EGRX Expected to Post Quarterly Sales of $51.50 Million https://t.co/niVBKztqcS May 21st 2018, 10:05am |
 |
@dakotafinancial Eagle Pharmaceuticals $EGRX Expected to Post Earnings of $0.96 Per Share https://t.co/B5PzH6Er8s May 21st 2018, 10:05am |
|
@dailypoliticaln Analysts Anticipate Eagle Pharmaceuticals $EGRX Will Announce Earnings of $0.96 Per Share https://t.co/KKyUflY0xl May 21st 2018, 10:05am |
 |
@AmericanBanking Eagle Pharmaceuticals $EGRX Receives Consensus Rating of “Hold” from Analysts https://t.co/JLRB9WCwDX #stocks May 21st 2018, 9:05am |
|
@dakotafinancial Eagle Pharmaceuticals $EGRX Receives Consensus Rating of “Hold” from Analysts https://t.co/kepkwafeLj May 21st 2018, 9:05am |
|
@TheMarketsDaily Eagle Pharmaceuticals $EGRX Receives Consensus Rating of “Hold” from Brokerages https://t.co/EI7wXBphQz May 21st 2018, 9:05am |
|
@registrarjourn Eagle Pharmaceuticals $EGRX Receives Consensus Rating of “Hold” from Analysts https://t.co/34AEWtKhTz May 21st 2018, 9:05am |
|
@ThisLincolnian Eagle Pharmaceuticals $EGRX Receives Underperform Rating from Mizuho https://t.co/jlFkURzlqN May 21st 2018, 7:05am |
|
@TranscriptDaily Eagle Pharmaceuticals $EGRX Receives Underperform Rating from Mizuho https://t.co/0KIZujn2kN May 21st 2018, 4:05am |
 |
@TickerReport Eagle Pharmaceuticals $EGRX Receives Underperform Rating from Mizuho https://t.co/UUrZDEGzyR May 21st 2018, 4:05am |
|
@OlympiaReport Eagle Pharmaceuticals $EGRX Stock Rating Upgraded by BidaskClub https://t.co/xodZZKuO7X May 21st 2018, 2:05am |
 |
@dispatchtribune Mizuho Reaffirms Underperform Rating for Eagle Pharmaceuticals $EGRX https://t.co/5KuLX8mfhv May 20th 2018, 12:05pm |
|
@OlympiaReport Eagle Pharmaceuticals $EGRX Stock Rating Reaffirmed by Mizuho https://t.co/TNN1wIYOKd May 20th 2018, 12:05pm |
|
@TheMarketsDaily Eagle Pharmaceuticals $EGRX Upgraded by BidaskClub to Strong-Buy https://t.co/M7B7OS82n8 May 20th 2018, 9:05am |
|
@registrarjourn Eagle Pharmaceuticals $EGRX Upgraded by BidaskClub to Strong-Buy https://t.co/WxxthgXMVs May 20th 2018, 9:05am |
|
@AmericanBanking Eagle Pharmaceuticals $EGRX Rating Increased to Strong-Buy at BidaskClub https://t.co/tW4F2lp64X #stocks May 19th 2018, 1:05pm |
|
@registrarjourn Eagle Pharmaceuticals $EGRX Stock Rating Reaffirmed by Mizuho https://t.co/g0ZOWsEBjj May 19th 2018, 9:05am |
|
@registrarjourn Brokerages Anticipate Eagle Pharmaceuticals $EGRX to Announce $0.96 EPS https://t.co/Rnjem2dbX9 May 19th 2018, 6:05am |
|
@WeekHerald Eagle Pharmaceuticals $EGRX Upgraded by BidaskClub to “Strong-Buy” https://t.co/I39PfAydWL May 19th 2018, 6:05am |
|
@ZolmaxNews Brokerages Anticipate Eagle Pharmaceuticals $EGRX to Announce $0.96 EPS https://t.co/pExRtN4RvH May 19th 2018, 5:05am |
|
@dailypoliticaln Eagle Pharmaceuticals $EGRX Upgraded by BidaskClub to “Strong-Buy” https://t.co/MLyGd0q8SB May 19th 2018, 4:05am |
|
@TickerReport Eagle Pharmaceuticals $EGRX Upgraded by BidaskClub to “Strong-Buy” https://t.co/uxEHyBZGrl May 19th 2018, 4:05am |
|
@dakotafinancial Eagle Pharmaceuticals $EGRX Given “Underperform” Rating at Mizuho https://t.co/cXkNu6x6t2 May 18th 2018, 2:05pm |
|
@TheMarketsDaily Eagle Pharmaceuticals $EGRX Earns “Underperform” Rating from Mizuho https://t.co/kyEelVUiid May 18th 2018, 2:05pm |
|
@ledgerzette Eagle Pharmaceuticals $EGRX Given “Underperform” Rating at Mizuho https://t.co/02LrS7SLv9 May 18th 2018, 2:05pm |
 |
@tymorapro $EGRX: Exc 6MoHIGH=68.79, hits:1, Rng:27%, ch:+0.5%, AtPivPt, tf:1111110, lowFlt:11M, HiPctSht[33%:11d], DyVol:3T:0… https://t.co/kyTQ8hRP0h May 18th 2018, 9:05am |
 |
@ConsumerFeed $51.50 Million in Sales Expected for Eagle Pharmaceuticals $EGRX This Quarter https://t.co/Jp0s23hnI4 May 18th 2018, 1:05am |
|
@AmericanBanking $51.50 Million in Sales Expected for Eagle Pharmaceuticals $EGRX This Quarter https://t.co/CvMX3Gy4QQ #stocks May 18th 2018, 1:05am |
|
@AmericanBanking Eagle Pharmaceuticals’ $EGRX Underperform Rating Reaffirmed at Mizuho https://t.co/l6DW0Riyzc #stocks May 17th 2018, 3:05pm |
|
@tymorapro $EGRX: At 6MoHIGH=68.79, hits:1, Rng:27%, ch:+1.6%, 0phNearHi, AtgPivH4, 2:4Accel+Dy, allTFs+, lowFlt:11M, HiPctSht[33%:11d] May 17th 2018, 12:05pm |
|
@dailypoliticaln Mizuho Reiterates “Underperform” Rating for Eagle Pharmaceuticals $EGRX https://t.co/gO8qV6u2Ka May 17th 2018, 8:05am |
|
@ZolmaxNews Mizuho Reiterates “Underperform” Rating for Eagle Pharmaceuticals $EGRX https://t.co/GJ37KlT3sG May 17th 2018, 8:05am |
|
@AmericanBanking Eagle Pharmaceuticals $EGRX Expected to Announce Earnings of $0.96 Per Share https://t.co/Y5SgCsKms9 #stocks May 16th 2018, 11:05pm |
|
@ThisLincolnian Eagle Pharmaceuticals $EGRX Expected to Announce Earnings of $0.96 Per Share https://t.co/wlPFGK5Ldc May 16th 2018, 11:05pm |
|
@OlympiaReport Analysts Anticipate Eagle Pharmaceuticals $EGRX to Announce $0.96 EPS https://t.co/B7C1z8aswc May 16th 2018, 11:05pm |
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.